Article Text

Download PDFPDF
Choroidal schwannoma: a case series of five patients
  1. Bertil Damato1,2,3,
  2. Erika M Damato1,
  3. Lazaros Konstantinidis1,
  4. Heinrich Heimann1,
  5. Sarah E Coupland2
  1. 1Vitreoretinal and Ocular Oncology Service, Royal Liverpool University Hospital, Liverpool, UK
  2. 2Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK
  3. 3Ocular Oncology Service, University of California, San Francisco, USA
  1. Correspondence to Dr Bertil Damato, Ocular Oncology Service, University of California, San Francisco, 10 Koret Way, K327, San Francisco, CA 94143-0730, USA; DamatoB{at}


Aim To report a case series of five patients diagnosed with choroidal schwannoma at the Liverpool Ocular Oncology Centre.

Methods Patients with choroidal schwannoma were identified by searching the computerised database of the Liverpool Ocular Oncology Centre.

Results The patients (3 males, 2 females) ranged in age from 15 years to 45 years. Three tumours were treated by enucleation, trans-scleral local resection, and combined bevacizumab and photodynamic therapy, respectively. Two were observed after confirmation of the diagnosis by biopsy.

Conclusions Choroidal schwannoma has a variety of clinical manifestations. Associated features include hard exudates, retinal feeder vessels and serous retinal detachment. Biopsy with immunohistochemistry is required for diagnosis. Tumours not amenable to resection may respond to photodynamic therapy.

  • Neoplasia
  • Pathology
  • Treatment Surgery
  • Choroid

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.